Independent Financial Group LLC Buys New Position in VanEck Pharmaceutical ETF $PPH

Independent Financial Group LLC acquired a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 5,118 shares of the company’s stock, valued at approximately $532,000. Independent Financial Group LLC owned approximately 0.05% of VanEck Pharmaceutical ETF at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP bought a new stake in VanEck Pharmaceutical ETF in the 4th quarter worth about $42,134,000. BNP Paribas Financial Markets increased its position in shares of VanEck Pharmaceutical ETF by 176.2% during the 4th quarter. BNP Paribas Financial Markets now owns 300,000 shares of the company’s stock valued at $30,951,000 after purchasing an additional 191,371 shares during the last quarter. Revere Asset Management Inc bought a new stake in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth $15,628,000. UBS Group AG boosted its holdings in shares of VanEck Pharmaceutical ETF by 145.8% in the 4th quarter. UBS Group AG now owns 107,379 shares of the company’s stock worth $11,078,000 after buying an additional 63,692 shares during the last quarter. Finally, Qube Research & Technologies Ltd grew its position in VanEck Pharmaceutical ETF by 368.5% during the third quarter. Qube Research & Technologies Ltd now owns 75,844 shares of the company’s stock valued at $6,853,000 after buying an additional 59,654 shares during the period.

VanEck Pharmaceutical ETF Stock Up 1.2%

PPH opened at $109.95 on Friday. VanEck Pharmaceutical ETF has a twelve month low of $81.74 and a twelve month high of $112.58. The company’s 50-day moving average price is $106.34 and its two-hundred day moving average price is $105.61. The stock has a market cap of $938.97 million, a price-to-earnings ratio of 20.21 and a beta of 0.46.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Wednesday, July 1st were issued a dividend of $0.6248 per share. This represents a $2.50 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Wednesday, July 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.